Chemoinformaics analysis of 9,19-Cyclolanost-23-ene-3,25-diol
| Molecular Weight | 442.728 | nRot | 4 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 23 |
| Exact Molecular Weight | 442.381 | nRing | 5 |
| Solubility: LogS | -5.075 | nHRing | 0 |
| Solubility: LogP | 5.822 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 85.0436 |
| nHD | 2 | BPOL | 50.1604 |
| QED | 0.454 |
| Synth | 5.599 |
| Natural Product Likeliness | 3.396 |
| NR-PPAR-gamma | 0.119 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0 |
| HIA | 0.038 |
| CACO-2 | -4.879 |
| MDCK | 0.0000103 |
| BBB | 0.345 |
| PPB | 1.00095 |
| VDSS | 1.35 |
| FU | 0.0241289 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.301 |
| CYP2c19-inh | 0.056 |
| CYP2c19-sub | 0.933 |
| CYP2c9-inh | 0.12 |
| CYP2c9-sub | 0.616 |
| CYP2d6-inh | 0.078 |
| CYP2d6-sub | 0.661 |
| CYP3a4-inh | 0.38 |
| CYP3a4-sub | 0.327 |
| CL | 9.464 |
| T12 | 0.017 |
| hERG | 0.027 |
| Ames | 0.016 |
| ROA | 0.056 |
| SkinSen | 0.404 |
| Carcinogencity | 0.022 |
| EI | 0.066 |
| Respiratory | 0.66 |
| NR-Aromatase | 0.729 |
| Antiviral | No |
| Prediction | 0.727374 |